nach oben

Erschienen in:

01.03.2016 | Intelligenzminderung | Übersichten

Neuropädiatrische Differenzialdiagnostik der Mikrozephalie im Kindesalter

verfasst von: Maja von der Hagen, Julia B. Hennermann, Horst von Bernuth, Rainer John, Birgit Spors, PD Dr. Angela M. Kaindl

Erschienen in: medizinische genetik | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Eine Mikrozephalie betrifft 2–3 % der Bevölkerung und geht oftmals mit einer Intelligenzminderung einher. Die zugrunde liegende Reduktion des Gehirnvolumens kann sowohl durch exogene Faktoren als auch durch genetische Ursachen bedingt sein. Problematisch sind sowohl die uneinheitliche Klassifikation als auch die große Heterogenität der hinter dem klinischen Zeichen Mikrozephalie stehenden Erkrankungen. Im vorliegenden Artikel stellen wir unseren Vorschlag für die diagnostische Herangehensweise an ein Kind mit Mikrozephalie aus neuropädiatrischer Sicht vor.

Opitz JM, Holt MC (1990) Microcephaly: general considerations and aids to nosology. J Craniofac Genet Dev Biol 10(2):175–204PubMed

Woods CG (2004) Human microcephaly. Curr Opin Neurobiol 14(1):112–117CrossRefPubMed

Ashwal S, Michelson D, Plawner L, Dobyns WB (2009) Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 73(11):887–897CrossRefPubMedPubMedCentral

von der Hagen M, Pivarcsi M, Liebe J, von Bernuth H, Didonato N, Hennermann JB et al (2014) Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature. Dev Med Child Neurol 56(8):732–741CrossRefPubMed

Pryor HB, Thelander H (1968) Abnormally small head size and intellect in children. J Pediatr 73(4):593–598CrossRefPubMed

Abuelo D (2007) Microcephaly syndromes. Semin Pediatr Neurol 14(3):118–127CrossRefPubMed

Leroy JG, Frias JL (2005) Nonsyndromic microcephaly: an overview. Adv Pediatr 52:261–293CrossRefPubMed

Dekaban AS (1978) Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol 4(4):345–356CrossRefPubMed

Nellhaus G (1968) Head circumference from birth to eighteen years. Practical composite international and interracial graphs. Pediatrics 41(1):106–114PubMed

10.

Prader A, Largo RH, Molinari L, Issler C (1989) Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 52:1–125PubMed

11.

Schienkiewitz A, Schaffrath Rosario A, Dortschy R, Ellert U, Neuhauser H (2011) German head circumference references for infants, children and adolescents in comparison with currently used national and international references. Acta Paediatr 100(7):e28–33CrossRefPubMed

12.

Ifflaender S, Rudiger M, Koch A, Burkhardt W (2013) Three-dimensional digital capture of head size in neonates – a method evaluation. PLOS One 8(4):e61274CrossRefPubMedPubMedCentral

13.

McQuillen PS, Miller SP (2010) Congenital heart disease and brain development. Ann N Y Acad Sci 1184:68–86CrossRefPubMed

14.

Buhrer C, Kaindl AM (2010) Common molecular causes for congenital heart defects and microcephaly. Am J Obstet Gynecol 202(2):e7 (author reply e‑8)CrossRefPubMed

15.

Barbu D, Mert I, Kruger M, Bahado-Singh RO (2009) Evidence of fetal central nervous system injury in isolated congenital heart defects: microcephaly at birth. Am J Obstet Gynecol 201(1):43 e1–43 e7CrossRefPubMed

16.

Sells CJ (1977) Microcephaly in a normal school population. Pediatrics 59(2):262–265PubMed

17.

Stoll C, Alembik Y, Dott B, Roth MP (1997) Congenital eye malformations in 212,479 consecutive births. Ann Genet 40(2):122–128PubMed

18.

Goyal R, Thompson D, Timms C, Wilson LC, Russell-Eggitt I (2008) Review of cases presenting with microcephaly and bilateral congenital cataract in a paediatric cataract clinic. Eye 22(2):273–281CrossRefPubMed

19.

Wiznitzer M, Rapin I, Van de Water TR (1987) Neurologic findings in children with ear malformations. Int J Pediatr Otorhinolaryngol 13(1):41–55CrossRefPubMed

20.

O’Connell EJ, Feldt RH, Stickler GB (1965) Head circumference, mental retardation, and growth failure. Pediatrics 36:62–66PubMed

21.

Watemberg N, Silver S, Harel S, Lerman-Sagie T (2002) Significance of microcephaly among children with developmental disabilities. J Child Neurol 17(2):117–122CrossRefPubMed

22.

Barmeyer GH (1971) Magic, science, and head circumference. Rocky Mt Med J 68(5):42–44PubMed

23.

Desch LW, Anderson SK, Snow JH (1990) Relationship of head circumference to measures of school performance. Clin Pediatr (Phila) 29(7):389–392CrossRef

24.

Smith RD (1981) Abnormal head circumference in learning-disabled children. Dev Med Child Neurol 23(5):626–632PubMed

25.

Somasundaram O, Papakumari R, Rajeswari R, Vijayalakshmi S (1976) Microcephaly. Indian J Pediatr 43(337):21–27CrossRefPubMed

26.

Coronado R, Giraldo J, Macaya A, Roig M (2012) Head circumference growth function as a marker of neurological impairment in a cohort of microcephalic infants and children. Neuropediatrics 43(5):271–274CrossRefPubMed

27.

Dolk H (1991) The predictive value of microcephaly during the first year of life for mental retardation at seven years. Dev Med Child Neurol 33(11):974–983CrossRefPubMed

28.

Abdel-Salam GM, Halasz AA, Czeizel AE (2000) Association of epilepsy with different groups of microcephaly. Dev Med Child Neurol 42(11):760–767CrossRefPubMed

29.

Qazi QH, Reed TE (1973) A problem in diagnosis of primary versus secondary microcephaly. Clin Genet 4(1):46–52CrossRefPubMed

30.

Berg AT, Levy SR, Novotny EJ, Shinnar S (1996) Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia 37(1):24–30CrossRefPubMed

31.

Chawla S, Aneja S, Kashyap R, Mallika V (2002) Etiology and clinical predictors of intractable epilepsy. Pediatr Neurol 27(3):186–191CrossRefPubMed

32.

Aneja S, Ahuja B, Taluja V, Bhatia VK (2001) Epilepsy in children with cerebral palsy. Indian J Pediatr 68(2):111–115CrossRefPubMed

33.

von Spiczak S, Caliebe A, Helbig I, Stephani U (2011) Genetische Ursachen epileptischer Enzephalopathien. Z Epileptol 24:108–113CrossRef

34.

Lemke JR, Bürki SE (2013) Genetik der infantilen epileptischen Enzephalopathien. Epileptologie 30:5–13

35.

Deprez L, Jansen A, De Jonghe P (2009) Genetics of epilepsy syndromes starting in the first year of life. Neurology 72(3):273–281CrossRefPubMed

36.

Mefford HC, Yendle SC, Hsu C, Cook J, Geraghty E, McMahon JM et al (2011) Rare copy number variants are an important cause of epileptic encephalopathies. Ann Neurol 70(6):974–985CrossRefPubMedPubMedCentral

37.

Mühling J (1995) Kraniofaziale Chirurgie. In: Hausamen EME, Reuther J (Hrsg) Kirschnersche allgemeine und spezielle Operationslehre. Springer, Berlin

38.

Marchac D, Renier D (1989) Craniosynostosis. World J Surg 13(4):358–365CrossRefPubMed

39.

Freudlsperger C, Castrillon-Oberndorfer G, Hoffmann J, Engel M (2013) Isolierte, nichtsyndromale Kraniosynostosen. Aktuelle Diagnostik- und Therapiekonzepte. MKG-Chirurg 6:301–313CrossRef

40.

Jaworski M, Hersh JH, Donat J, Shearer LT, Weisskopf B (1986) Computed tomography of the head in the evaluation of microcephaly. Pediatrics 78(6):1064–1069PubMed

41.

Steinlin M, Zurrer M, Martin E, Boesch C, Largo RH, Boltshauser E (1991) Contribution of magnetic resonance imaging in the evaluation of microcephaly. Neuropediatrics 22(4):184–189CrossRefPubMed

42.

Sugimoto T, Yasuhara A, Nishida N, Murakami K, Woo M, Kobayashi Y (1993) MRI of the head in the evaluation of microcephaly. Neuropediatrics 24(1):4–7CrossRefPubMed

43.

Bodensteiner J, Schaefer GB, Breeding L, Cowan L (1994) Hypoplasia of the corpus callosum: a study of 445 consecutive MRI scans. J Child Neurol 9(1):47–49CrossRefPubMed

44.

Glass HC, Shaw GM, Ma C, Sherr EH (2008) Agenesis of the corpus callosum in California 1983–2003: a population-based study. Am J Med Genet A 146A(19):2495–2500CrossRefPubMedPubMedCentral

45.

Paul LK (2011) Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement. J Neurodev Disord 3(1):3–27CrossRefPubMedPubMedCentral

46.

Wieczorek DBH, Hennermann JB, John R, Bührer C, Kaindl AM (2013) Diagnostik bei Kindern mit primärer Mikrozephalie. Neuropädiatrie Klin Prax 12(1):38–50

47.

Bonnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A et al (2014) Diagnostic approach to the congenital muscular dystrophies. Neuromuscular disorders. NMD 24(4):289–311PubMed

48.

Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B et al (2007) Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain 130(10):2725–2735CrossRefPubMed

49.

Tabatabaie L, Klomp LW, Berger R, de Koning TJ (2010) L‑serine synthesis in the central nervous system: a review on serine deficiency disorders. Mol Genet Metab 99(3):256–262CrossRefPubMed

50.

Goldenberg A, Chevy F, Bernard C, Wolf C, Cormier-Daire V (2003) Clinical characteristics and diagnosis of Smith-Lemli-Opitz syndrome and tentative phenotype-genotype correlation: report of 45 cases. Arch Pediatr 10(1):4–10CrossRefPubMed

51.

Barnerias C, Saudubray JM, Touati G, De Lonlay P, Dulac O, Ponsot G et al (2010) Pyruvate dehydrogenase complex deficiency: four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol 52(2):e1–9CrossRefPubMed

52.

van Straaten HL, van Tintelen JP, Trijbels JM, van den Heuvel LP, Troost D, Rozemuller JM et al (2005) Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruption. Neuropediatrics 36(3):193–199CrossRefPubMed

53.

Siu VM, Ratko S, Prasad AN, Prasad C, Rupar CA (2010) Amish microcephaly: Long-term survival and biochemical characterization. Am J Med Genet A 152A(7):1747–1751CrossRefPubMed

54.

Kranz C, Sun L, Eklund EA, Krasnewich D, Casey JR, Freeze HH (2007) CDG-Id in two siblings with partially different phenotypes. Am J Med Genet A 143A(13):1414–1420CrossRefPubMed

55.

Schollen E, Grunewald S, Keldermans L, Albrecht B, Korner C, Matthijs G (2005) CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter). Eur J Med Genet 48(2):153–158CrossRefPubMed

56.

Morava E, Vodopiutz J, Lefeber DJ, Janecke AR, Schmidt WM, Lechner S et al (2012) Defining the Phenotype in Congenital Disorder of Glycosylation Due to ALG1 Mutations. Pediatrics 130(4):e1034–e1039CrossRefPubMed

57.

Morava E, Zeevaert R, Korsch E, Huijben K, Wopereis S, Matthijs G et al (2007) A common mutation in the COG7 gene with a consistent phenotype including microcephaly, adducted thumbs, growth retardation, VSD and episodes of hyperthermia. Eur J Hum Genet 15(6):638–645CrossRefPubMed

58.

Chenel C, Wood C, Gourrier E, Zittoun J, Casadevall I, Ogier H (1993) Neonatal hemolytic-uremic syndrome, methylmalonic aciduria and homocystinuria caused by intracellular vitamin B 12 deficiency. Value of etiological diagnosis. Arch Fr Pediatr 50(9):749–754PubMed

59.

Gailus S, Suormala T, Malerczyk-Aktas AG, Toliat MR, Wittkampf T, Stucki M et al (2010) A novel mutation in LMBRD1 causes the cblF defect of vitamin B(12) metabolism in a Turkish patient. J Inherit Metab Dis 33(1):17–24CrossRefPubMed

60.

Busche A, Hennermann JB, Burger F, Proquitte H, Dierks T, von Arnim-Baas A et al (2009) Neonatal manifestation of multiple sulfatase deficiency. Eur J Pediatr 168(8):969–973CrossRefPubMed

61.

Fritchie K, Siintola E, Armao D, Lehesjoki AE, Marino T, Powell C et al (2009) Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10). Acta Neuropathol 117(2):201–208CrossRefPubMed

62.

Mayatepek E, Flock B (1998) Leukotriene C4-synthesis deficiency: a new inborn error of metabolism linked to a fatal developmental syndrome. Lancet 352(9139):1514–1517CrossRefPubMed

63.

Ben-Salem S, Gleeson JG, Al-Shamsi AM, Islam B, Hertecant J, Ali BR et al (2015) Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay. Metab Brain Dis 30(3):687–694CrossRefPubMed

64.

Alfadhel M, Alrifai MT, Trujillano D, Alshaalan H, Othaim AA, Rasheed AS et al (2015) Asparagine Synthetase Deficiency: New Inborn Errors of Metabolism. JIMD Rep 22:11–16CrossRefPubMedPubMedCentral

65.

Carmi-Nawi N, Malinger G, Mandel H, Ichida K, Lerman-Sagie T, Lev D (2011) Prenatal brain disruption in molybdenum cofactor deficiency. J Child Neurol 26(4):460–464CrossRefPubMed

66.

Romano C (2010) The clinical evaluation of patients with mental retardation/intellectual disability. In: Knight SJL (Hrsg) Genetics of Mental Retardation, 18. Aufl. Karger, Basel, S 57–66CrossRef

67.

Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C et al (2011) A copy number variation morbidity map of developmental delay. Nat Genet 43(9):838–846CrossRefPubMedPubMedCentral

68.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP et al (2010) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86(5):749–764CrossRefPubMedPubMedCentral

69.

Shoukier M, Klein N, Auber B, Wickert J, Schroder J, Zoll B et al (2013) Array CGH in patients with developmental delay or intellectual disability: are there phenotypic clues to pathogenic copy number variants? Clin Genet 83(1):53–65CrossRefPubMed

70.

Kaindl AM, Passemard S, Kumar P, Kraemer N, Issa L, Zwirner A et al (2010) Many roads lead to primary autosomal recessive microcephaly. Prog Neurobiol 90(3):363–383CrossRefPubMed

71.

Kraemer N, Issa L, Hauck SC, Mani S, Ninnemann O, Kaindl AM (2011) What’s the hype about CDK5RAP2? Cell Mol Life Sci 68(10):1719–1736CrossRefPubMed

72.

Kraemer NM-RD, Kaindl AM (2013) Primäre autosomal-rezessive Mikrozephalie (MCPH). Neuropädiatrie Klin Prax 1(1):5–12

73.

Kaindl AM (2014) Autosomal recessive primary microcephalies (MCPH). Eur J Paediatr Neurol 18(4):547–548CrossRefPubMed

74.

Nagy G, Ackerman SL (2013) Cholesterol metabolism and Rett syndrome pathogenesis. Nat Genet 45(9):965–967CrossRefPubMed

75.

Huang HS, Allen JA, Mabb AM, King IF, Miriyala J, Taylor-Blake B et al (2012) Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481(7380):185–189CrossRefPubMedCentral

76.

Barresi R, Michele DE, Kanagawa M, Harper HA, Dovico SA, Satz JS et al (2004) LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 10(7):696–703CrossRefPubMed

77.

Robertson NJ, Faulkner S, Fleiss B, Bainbridge A, Andorka C, Price D et al (2013) Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain 136(1):90–105CrossRefPubMed

78.

Saliba E, Favrais G, Gressens P (2007) Neuroprotection of the newborn: from bench to cribside. Seminars Fetal Neonatal Med 12(4):239–240CrossRef

Titel: Neuropädiatrische Differenzialdiagnostik der Mikrozephalie im Kindesalter
verfasst von: Maja von der Hagen
Julia B. Hennermann
Horst von Bernuth
Rainer John
Birgit Spors
PD Dr. Angela M. Kaindl
Publikationsdatum: 01.03.2016
Verlag: Springer Berlin Heidelberg
Schlagwörter: Intelligenzminderung
Intelligenzminderung
Muskeldystrophie
Muskeldystrophie
Erschienen in: medizinische genetik / Ausgabe 1/2016
Print ISSN: 0936-5931
Elektronische ISSN: 1863-5490
DOI: https://doi.org/10.1007/s11825-016-0081-7

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Abstracts

27. Jahrestagung der Deutschen Gesellschaft für Humangenetik

Mitteilungen des BVDH

Mitteilungen der GfH

RASopathien

50 Jahre Klinische Genetik in Tübingen